RIANA Therapeutics GmbH
Developing novel anti-cancer therapies

Founded

08.02.2023

Staff

3

Organization type

RDM biotech/pharma

Region

Vienna

Cluster

LISAvienna

Focus

human health

RIANA Therapeutics' approach to drug discovery is based on its proprietary platform technology for discovering compounds that target cancer-promoting protein-protein interactions (PPIs). Using this novel approach, RIANA is searching for inhibitors that block the formation of specific oncogenic PPIs. RIANA is currently working to develop new compounds that specifically target acute myeloid leukemia (AML) as well as other blood cancers and certain types of solid tumors.